Type 2 Diabetes Patients Benefit From Bone Marrow Stem Cell Transplants

Editor's Choice Academic Journal Main Category: Diabetes Also Included In: Stem Cell Research;Transplants / Organ Donations Article Date: 01 Jul 2013 - 0:00 PDT

Current ratings for: Type 2 Diabetes Patients Benefit From Bone Marrow Stem Cell Transplants

The research, published in Cell Transplantation, was carried out in India and looked at the safety and efficacy of autologous transplanted bone marrow stem cells in patients with type 2 diabetes (TD2M).

Study corresponding author Anil Bhansali, PhD, professor and head of the Endocrinology Department at the Post Graduate Institute of Medical Education in Chandrigarh, India, said:

Although there is an increasing interest in using stem cell transplantation to treat people with this condition, there has been little research observing the benefit of bone marrow-derived stem cells.

"By experimenting with bone marrow-derived stem cells, the researchers sought to exploit the rich source of stem cells in bone marrow," the researchers said.

The experts wanted to examine the efficacy and safety of autologous bone marrow-derived stem cell transplantation in patients with T2DM and who also had good glycemic control.

Good glycemic control appeared as a critical factor in the transplantation group and in the non-transplanted control group.

Cell transplantation had a considerable influence on the patients in this report as those administered cells showed a significant decrease in insulin requirement.

A notably smaller decrease in the need for insulin was also observed in the control group.

Link:
Type 2 Diabetes Patients Benefit From Bone Marrow Stem Cell Transplants

Related Post